The treatment landscape for patients with metastatic hormone-sensitive prostate cancer (mHSPC) has evolved dramatically in recent years, with multiple first-line options, including abiraterone acetate with prednisone or prednisolone (AAP), apalutamide, docetaxel, and enzalutamide, as well as radiation to the primary for de novo mHSPC, all demonstrating improved overall survival in combination…
Listen to ASCO’s Journal of Clinical Oncology essay, by Barry Meisenberg, Chair of Medicine and Director of Academic Affairs at Luminis Health. The essay is…
The Journal of Clinical Oncology features discussions of new and noteworthy results published in ASCO’s Journal of Clinical Oncology and how they impact clinical practice…
JCO’s Cancer Stories: The Art of Oncology podcast features stories, dialogue, and personal reflections that explore the experience of living with cancer or caring for…
The Journal of Clinical Oncology features discussions of new and noteworthy results published in ASCO’s Journal of Clinical Oncology and how they impact clinical practice…
Dr. Shannon Westin and her guests, Dr. Michael Atkins, Dr. Adil Daud, and Dr. Gary Schwartz, discuss a definitive work: . TRANSCRIPT The guests on…
TRANSCRIPT Listen to ASCO’s Journal of Clinical Oncology essay, “Cemetery Rounds” by David Steensma, a hematologist-oncologist in Boston. The essay is followed by an…
Your PrivacyASCO is committed to transparency regarding our websites and the ways we process data. When you visit our site, we may store or retrieve…
Host Dr. Shannon Westin interviews guests Dr. Ethan Basch and Dr Deborah Schrag on their JCO simultaneous publication paper at ASCO’s 2023 annual meeting: “Patient-reported…
Listen to ASCO’s Journal of Clinical Oncology essay, “ by Dr. Rebecca Kowaloff, a Palliative Care Attending at the University of Massachusetts. The essay is…
Please review the available slots below and click on the button to sign up (all times shown in Central Time). You may sign up for…
